Enjoy complimentary customisation on priority with our Enterprise License!
The biopreservation market size is estimated to grow by USD 2.40 billion at a Compound annual growth rate (CAGR) of 15.88% between 2022 and 2027. The market is fueled by the escalating demand for personalized medicine, a surge in the number of biobanks, and the global rise in chronic diseases. As personalized medicine gains traction, biobanks are expanding to store diverse biological samples. Additionally, the prevalence of chronic diseases worldwide necessitates efficient storage and preservation of biological specimens for research and treatment, driving the market forward.
To learn more about this report, View Report Sample
This market growth analysis report extensively covers market segmentation by end-user (life sciences and healthcare facilities, research laboratories, and others), application (biobanks, regenerative medicine, and drug discovery), and geography (North America, Asia, Europe, and Rest of World (ROW)).
The life science and healthcare facilities segment is estimated to witness significant growth during the forecast period. The key factor that drives the growth of the life sciences and healthcare facilities segment is the growing prevalence of obesity and chronic diseases globally. The rising number of patients diagnosed with chronic diseases, such as cardiac ailments, diabetes, and degenerative conditions affecting the nerves, bones, and joints, is driving the demand for biopreservation in the life sciences and healthcare facilities segment.
Get a glance at the market contribution of various segments View the PDF Sample
The life science and healthcare facilities segment was the largest segment and was valued at USD 697.02 million in 2017. A major shortage of donors for organ transplants has increased the demand for regenerative medicine all over the world. Regenerative medicine is used for treating and controlling various degenerative conditions and chronic diseases. Regenerative medicine broadly requires biopreservation techniques to keep the functionality and integrity of cells, tissues, or organs undamaged. The growing usage of regenerative medicines is directly increasing the demand for biopreservation, which thereby will drive the growth of the life sciences and healthcare facilities segment of the market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In North America, biopreservation has emerged as an important feature of the research landscape over the past 15 years. Increasing funding from healthcare organizations, such as the National Institutes of Health (NIH), has fueled market growth in the region. The NIH continues to be the major source of funding and facilitator for biopreservation in the US. It is also focused on the biopreservation efforts in major healthcare institutions, such as the National Cancer Institute.
The market is experiencing robust growth. Hospitals, labs, and government entities, along with private partners, are investing heavily in healthcare research & development and product development. Leading companies like BioLife Solutions are pioneering advancements in controlled freezer technology to cater to the expanding cell and gene therapy market. This technology ensures the preservation of vital biological materials such as stem cells, DNA, tissues, and organs in their natural environment. Innovative solutions like microarrays, predictive models, and hybrid models powered by API algorithms enable efficient diagnostic and treatment measures, particularly in cardiology, gynecology, and point-of-care applications.
Our researchers analyzed the data with 2022 as the base year and the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The surging demand for personalized medicine is propelling market expansion. Meeting the substantial medical need to devise effective therapies for various diseases has spurred the requirement for personalized medicine, thus escalating the necessity for biopreservation. In this landscape, market players may find themselves in a transformative position. Personalized medicine tailors treatments to individual needs and preferences, prompting individuals to increasingly bank their tissues and stem cells for potential future treatments.
Crucially, personalized medicine relies on the availability of individual samples with annotated clinical and pathological data. Research institutions are currently exploring the potential of developing personalized treatments using biosamples. Biobanking, a form of biopreservation, significantly contributes to personalized medicine and genomics research. Consequently, the rising demand for personalized medicine is set to drive global demand for biopreservation, fostering market growth.
The emergence of stem cell storage in biobanks is a primary trend in the market. The demand for stem cell storage in biobanks is growing phenomenally and is expected to have a positive impact on the growth of the market during the forecast period. In areas like cardiology and oncology, scientists believe stem cells have the potential to respond to a wide range of needs that are not met. Therefore, the market is witnessing many new biobanking facilities that are particularly dedicated to stem cell research.
Moreover, research organizations are focusing on establishing advanced production or manufacturing units to improve supply chain efficiency, thereby boosting production capacities. For example, the adoption of IT in logistics to ease the monitoring of biobanking services and the development of temperature-controlled logistics solutions, such as cryopreservation, will help minimize manual errors besides producing large batches of stem cell therapy products in a closed, sterile environment. Such factors are likely to lead to substantial growth opportunities for the market during the forecast period.
Ethical issues are a major challenge in a market. Issues regarding privacy while accessing biological samples remain a major ethical issue with biopreservation, where protecting the identity of individuals is a major concern. The first step in the process of protection is the need for informed consent. Moreover, for private companies active on the market, the use of biobank information could be attempted in their own interests. Ethical questions concerning the preservation of biological samples have been under constant discussion for many years. In a number of countries, research carried out in the field of biological specimens like tissues and stem cells is also disputed.
Some of the ethical issues worth mentioning here include the cloning of embryonic stem cells and the destruction of embryos to create cell lines. Moreover, there is still a debate on safety concerns, scientific purity, and acceptance of the use of Human Embryo Stem Cell Lines in research. These factors may act as a hindrance to the growth of the market during the forecast period.
The market research and growth report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
AMS Biotechnology Europe Ltd. - The company offers biopreservation such as AMSbio CryoStor.
The market forecasting report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:
Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.
The market serves a crucial role across various sectors, including hospitals, labs, and government entities, often collaborating with private partners for research and development initiatives. It supports product development by providing controlled freezing environments for the storage of biological specimens essential for advancing cell and gene therapies, DNA research, and understanding disease progression. With ongoing technological innovations like microarrays and predictive models, biopreservation addresses challenges such as time, cost, and complexity in diagnostic and treatment measures. It caters to diverse applications, from gynecology to immunotherapies, vaccine production, and enzyme technology, combating health disorders like cardiovascular diseases. Government and private sectors, along with investors, contribute to healthcare spending, supporting skilled labor and cybersecurity measures to ensure data integrity and patient safety.
The market is witnessing significant advancements in research and development, particularly in technologies like controlled freezers and hybrid models, catering to the burgeoning cell and gene therapy market. With a focus on preserving biological samples in their natural environment, innovative solutions like API algorithms and multiplex cellular imaging platforms are emerging. These technologies facilitate diagnostic and treatment measures, especially in point-of-care applications and antibody production. Moreover, biopreservation supports the production of biologically produced chemicals, crucial in combating chronic diseases like cardiovascular disorders. Government sectors are collaborating to address rising chronic disease incidences, emphasizing skilled professional training and software standardization to optimize equipment efficiency across plasma, tissue culture, and media applications, ensuring reliable research data.
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Biopreservation Market Scope |
|
Report Coverage |
Details |
Page number |
153 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 15.88% |
Market growth 2023-2027 |
USD 2.40 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
15.34 |
Regional analysis |
North America, Asia, Europe, and Rest of the World (ROW) |
Performing market contribution |
North America at 40% |
Key countries |
US, Germany, France, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AMS Biotechnology Europe Ltd., ARCTIKO AS, Avantor Inc., Bio Techne Corp., BioLife Solutions Inc., Chart Industries Inc., Exact Sciences Corp., IC Biomedical LLC, Merck KGaA, NIPPON Genetics Europe GmbH, OPS Diagnostics LLC, PHC Holdings Corp., QIAGEN NV, Shanghai Genext Medical Technology Co. Ltd., So Low Environmental Equipment Co. Inc., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., ThermoGenesis Holdings Inc., Thomas Scientific LLC, and Trane Technologies Plc |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.